Search Results - "van Luijn, Johan C. F."

Choice of Comparator in Active Control Trials of New Drugs by van Luijn, Johan CF, van Loenen, Arie C, Gribnau, Frank WJ, Leufkens, Hubert GM

“…Background: When choosing the active control group in a randomized that, it is important to maintain standard treatment for the therapeutic indication for…”
Get full text

Is There a Role for Pharmacoeconomics in Decision Making? by van Luijn, Johan C. F.

Get full text

Superior efficacy of new medicines? by van Luijn, Johan C. F., Gribnau, Frank W. J., Leufkens, Hubert G. M.

“…Purpose To provide an overview of and discuss newly authorised medicines with an improved efficacy. Methods This analysis focussed on new medicines with an…”
Get full text

Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization by Van Luijn, Johan C. F., Gribnau, Frank W. J., Leufkens, Hubert G. M.

“…What is already known about this subject • The assessment of the added therapeutic value of new medicines with a new active substance is hampered by the lack…”
Get full text

Gap in publication of comparative information on new medicines by Van Luijn, Johan C. F., Stolk, Pieter, Gribnau, Frank W. J., Leufkens, Hubert G. M.

“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Randomized active control trials are used by health care professionals and reimbursement authorities for the…”
Get full text